Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis

F Grodstein, PA Newcomb, MJ Stampfer - The American journal of …, 1999 - Elsevier
PURPOSE: Colorectal cancer is the fourth most common cancer and the second leading
cause of cancer death in the United States. Accumulating evidence indicates that …

Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon

JPJ Issa, YL Ottaviano, P Celano, SR Hamilton… - Nature …, 1994 - nature.com
We report that CpG island methylation, an epigenetic modification of DNA known to correlate
closely with silencing of gene transcription, appears in the oestrogen receptor (ER) gene in …

Colorectal cancer diagnosed during pregnancy: systematic review and treatment pathways

G Pellino, C Simillis, C Kontovounisios… - European journal of …, 2017 - journals.lww.com
The aim of this study was to identify the mode of presentation and incidence of colorectal
cancer in pregnancy (CRC-p), assess the outcomes of the mother and foetus according to …

Colon and rectal cancer in pregnancy

MA Bernstein, RD Madoff… - Diseases of the colon & …, 1993 - journals.lww.com
Colorectal carcinoma presenting in pregnancy is an uncommon disease that is reported to
be associated with an extremely poor prognosis. To better characterize this disease, we …

Flaxseed supplementation and early markers of colon carcinogenesis

M Serraino, LU Thompson - Cancer letters, 1992 - Elsevier
Since flaxseed ingestion produces potentially anticarcinogenic lignans in the colon, this
study determined whether flaxseed decreases the risk for colon carcinogenesis. Following a …

Hormone replacement therapy is associated with lower risk of adenomatous polyps of the large bowel: the Minnesota Cancer Prevention Research Unit Case-Control …

JD Potter, RM Bostick, GA Grandits, L Fosdick… - … , biomarkers & prevention …, 1996 - AACR
Evidence of a role for steroid hormones and reproduction in colon neoplasia remains
tantalizing but unclear. Hormone replacement therapy (HRT) has been reported in a number …

Progesterone receptor immunoreactivity in pancreatic endocrine tumors. An immunocytochemical study of 156 neuroendocrine tumors of the pancreas …

G Viale, C Doglioni, M Gambacorta, G Zamboni… - Cancer, 1992 - Wiley Online Library
Background. The immunoreactivity for progesterone receptors (PR) of the majority of
endocrine cells of the human pancreas has prompted the authors to investigate if PR …

ERβ isoform expression in colorectal carcinoma: an in vivo and in vitro study of clinicopathological and molecular correlates

NACS Wong, RDG Malcomson… - The Journal of …, 2005 - Wiley Online Library
Colorectal carcinoma shows several sex‐related differences with regard to incidence,
response to chemotherapy and microsatellite instability. These differences may relate to …

Estrogen and progesterone receptors in colon tumors

ML Slattery, WS Samowitz… - American journal of …, 2000 - academic.oup.com
Existing data suggest that there is a hormonal basis to the cause of colon cancer. In the
present study, we evaluated the presence of estrogen receptors (ERs) and progesterone …

Estrogen receptor β as a prognostic marker of tumor progression in colorectal cancer with familial adenomatous polyposis and sporadic polyps

PR Stevanato Filho, S Aguiar Junior… - Pathology & Oncology …, 2018 - Springer
The incidence of colorectal cancer (CRC) is lower in women than in men, and sex steroids
can be considered contributing factors because oral contraception usage and estrogen …